This website uses cookies

We use cookies and website tracking tools to provide you with the best online experience. Learn more in our /en/news/hih-news/privacy-notice/privacy statement.

if you accept, your choice will be valid until cancellation.

If you disallow cookies, functionality of our website might be limited.

 

HIH News

"What has been approved in the U.S. is something completely new"

Last Monday, the U.S. Food and Drug Administration (FDA) approved the Alzheimer's drug aducanumab, using its "accelerated approval" program. Prof. Dr. Mathias Jucker talks about the drug with the Hertie Foundation (interview in German only).

Prof. Dr. Mathias Jucker